Structural Elucidation of the Novel RNA Polymerase Underlying Francisella Tularensis Virulence
土拉弗朗西斯菌毒力背后的新型 RNA 聚合酶的结构解析
基本信息
- 批准号:9977601
- 负责人:
- 金额:$ 23.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAutomobile DrivingBacteriaBindingBinding SitesBiochemicalBiological AssayC-terminalCategoriesCellsChIP-seqComplexCryoelectron MicroscopyDNA-Binding ProteinsDNA-Directed RNA PolymeraseDangerousnessDevelopmentDisease OutbreaksDissectionDockingFluorescence PolarizationFrancisellaFrancisella tularensisGene ActivationGenesGenetic TranscriptionGoalsGovernmentGrowthGuanosine TetraphosphateHelix-Turn-Helix MotifsHeterodimerizationHoloenzymesHumanInfectionInfectious AgentKnowledgeLaboratoriesMapsMediatingMedical centerMolecularMorbidity - disease ratePathogenicityPathogenicity IslandPolymeraseProteinsRNA Polymerase IRNA Polymerase IIRegulator GenesResearchResolutionSignal TransductionStarvationState GovernmentStressStructureSystemTailTestingTherapeuticTranscriptional ActivationTranscriptional RegulationTularemiaUnited StatesVirulenceVirulence FactorsWinged Helixaerosolizedbioweaponcell typedesignexperimental studyinhibitor/antagonistinsightmacrophagemanmortalitynew therapeutic targetnovelnovel therapeuticspathogenic bacteriaprogramspromoterrecruitstructural biology
项目摘要
Francisella tularensis, the causative agent of tularemia, is one of the most infectious bacterial pathogens
known. This bacterium can be readily aerosolized and utilized as a bioweapon. The morbidity and mortality of
tularemia are significant and, given the infectious capability of Francisella, a major outbreak would readily
overwhelm the ability of even the largest U.S. medical centers. Consequently, Francisella is classified as a
category A bioweapon by the US government. Genes encoded on the Francisella pathogenicity island (FPI),
are responsible for the virulence of this bacterium. The stringent starvation protein A (SspA), the macrophage
growth locus protein A (MglA) and the pathogenicity island gene regulator (PigR) mediate activation of these
genes and are therefore essential for the virulence of Francisella species that infect humans. MglA and PigR
are unique to Francisella whereas SspA proteins are found in multiple bacteria. The Francisella SspA,
however, is unusual in that it does not homodimerize but rather functions as a heterodimer with MglA. PigR is a
putative DNA binding protein with a predicted winged-helix-turn-helix motif. How SspA-MglA and PigR mediate
FPI activation is unknown, as is the underlying molecular mechanism that these proteins use to sense
infection. The overarching goal of this proposal is the molecular dissection of these mechanisms through the
study of these virulence factors in the human pathogenic Francisella tularensis tularensis and holartica
subspecies. Early studies implicated the “alarmone”, guanosine-tetraphosphate (ppGpp), as key for Francisella
virulence. We recently showed that ppGpp binds directly to MglA-SspA and unveiled the molecular details of
this interaction by solving the MglA-SspA-ppGpp complex structure. Further, we showed that ppGpp binding to
MglA-SspA mediates high affinity binding of PigR to this heterodimer. In this revised proposal, we shall
leverage our recent discoveries to dissect all components of the Francisella virulence regulatory system,
including critically, the Francisella RNA polymerase (RNAP). Our central hypothesis is that F. tularensis
employs a conceptually novel form of virulence activation involving a unique RNAP that contains the virulence
activating complex MglA-SspA as a core constituent. This is supported by ChIP-seq studies and RNAP
purifications from Francisella cells. We shall test our central hypothesis and complete the proposed objectives
through two Specific Aims. Specific Aim 1: Elucidate the high resolution structure of (MglA-SspA)-ppGpp-PigR
and identify inhibitors of ppGpp binding to MglA-SspA. Specific Aim 2: Determine the structure of Francisella
RNAP complexes by cryo-EM. The successful completion of these studies will reveal a new paradigm in
transcription regulation and enable the rational design of novel anti-Francisella-virulence therapeutics.
francisella tularensis是tularemia的病因,是最感染性细菌病原体之一
已知。该细菌可以很容易被雾化并用作生物武器。发病率和死亡率
Tularemia很重要,鉴于Francisella的感染能力,很容易爆发
即使是最大的美国医疗中心的能力,也压倒了能力。因此,弗朗西斯拉被归类为
美国政府的生物武器类别。在Francisella致病岛(FPI)上编码的基因,
负责该细菌的病毒。严格的饥饿蛋白A(SSPA),巨噬细胞
生长基因座蛋白A(MGLA)和致病性岛基因调节剂(PIGR)介导了这些激活
基因,因此对于感染了人类的弗朗西斯氏菌的病毒至关重要。 MGLA和PIGR
弗朗西斯菌是独有的,而SSPA蛋白在多种细菌中发现。 Francisella SSPA,
但是,这是不寻常的,因为它不会同构二聚体,而是作为MGLA的异二聚体起作用。 Pigr是一个
推定的DNA结合蛋白具有预测的翼螺旋 - 螺旋螺旋序。 SSPA-MGLA和PIGR如何介导
FPI激活尚不清楚,这些蛋白质用来感知的基本分子机制也是
感染。该提案的总体目标是通过这些机制的分子解剖
研究这些病毒因子在人类致病性francisella tularensis和holartica中的研究
亚种。早期研究牵涉到“警报器”,鸟苷 - 四磷酸盐(PPGPP),作为弗朗西斯拉的关键
病毒。我们最近表明,PPGPP直接与MGLA-SSPA结合,并揭示了分子细节
通过求解MGLA-SSPA-PPGPP复合结构的相互作用。此外,我们表明PPGPP与
MGLA-SPA介导了PIGR与该异二聚体的高亲和力结合。在这项修订的建议中,我们将
利用我们最近的发现来剖析弗朗西斯氏病毒调节系统的所有组成部分,
包括批判性的Francisella RNA聚合酶(RNAP)。我们的中心假设是F. tularensis
员工一种概念性小说的病毒激活形式涉及一个独特的RNAP,其中包含病毒
激活复杂的MGLA-SSPA作为核心。这得到了Chip-Seq研究和RNAP的支持
Francisella细胞的纯化。我们将检验我们的中心假设并完成提议的目标
通过两个具体的目标。特定目标1:阐明(MGLA-SPA)-PPGPP-PIGR的高分辨率结构
并鉴定PPGPP与MGLA-SSPA结合的抑制剂。特定目标2:确定弗朗西斯拉的结构
Cryo-Em的RNAP复合物。这些研究的成功完成将揭示一个新的范式
转录调节并使新型抗素养病毒治疗的合理设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD GERALD BRENNAN其他文献
RICHARD GERALD BRENNAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD GERALD BRENNAN', 18)}}的其他基金
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10242477 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10611505 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Molecular elucidation of the Francisella tularensis virulence mechanism
土拉弗朗西斯菌毒力机制的分子阐明
- 批准号:
10408864 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Structural Elucidation of the Novel RNA Polymerase Underlying Francisella Tularensis Virulence
土拉弗朗西斯菌毒力背后的新型 RNA 聚合酶的结构解析
- 批准号:
10089396 - 财政年份:2020
- 资助金额:
$ 23.42万 - 项目类别:
Defining the structural mechanisms of Hfq binding to cognate nucleic acids
定义 Hfq 与同源核酸结合的结构机制
- 批准号:
9094550 - 财政年份:2015
- 资助金额:
$ 23.42万 - 项目类别:
Trehalose Pathway for Antifungal Targets and Inhibitors
抗真菌靶点和抑制剂的海藻糖途径
- 批准号:
8931205 - 财政年份:2015
- 资助金额:
$ 23.42万 - 项目类别:
Defining the structural mechanisms of Hfq binding to cognate nucleic acids
定义 Hfq 与同源核酸结合的结构机制
- 批准号:
8809577 - 财政年份:2015
- 资助金额:
$ 23.42万 - 项目类别:
STRUCTURAL MECHANISM OF THE T GONDII UPRT, A TARGET FOR STRUCTURAL-BASED DRUG D
T GONDII UPRT 的结构机制,基于结构的药物 D 的靶标
- 批准号:
7721784 - 财政年份:2008
- 资助金额:
$ 23.42万 - 项目类别:
CRYSTALLOGRAPHIC STUDIES OF GLUTAMINE SYNTHETASE AND TNRA FROM BACILLUS SUBTILIS
枯草芽孢杆菌谷氨酰胺合成酶和 TNRA 的晶体学研究
- 批准号:
7721786 - 财政年份:2008
- 资助金额:
$ 23.42万 - 项目类别:
相似国自然基金
基于驾驶人行为理解的人机共驾型智能汽车驾驶权分配机制研究
- 批准号:52302494
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
有条件自动驾驶汽车驾驶人疲劳演化机理与协同调控方法
- 批准号:52372341
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
人机共驾汽车驾驶风险分析及控制权智能交互机理
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
人机共驾汽车驾驶风险分析及控制权智能交互机理
- 批准号:52272413
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
定性与定量分析跟驰行驶中汽车驾驶员情感-行为交互作用机理
- 批准号:71901134
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 23.42万 - 项目类别:
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
心磷脂在革兰氏阴性细菌细胞包膜生物发生中的作用
- 批准号:
10731444 - 财政年份:2023
- 资助金额:
$ 23.42万 - 项目类别:
Controlled antibiotic delivery vehicle for treatment of aggressiveperiodontitis
用于治疗侵袭性牙周炎的受控抗生素递送载体
- 批准号:
10662640 - 财政年份:2023
- 资助金额:
$ 23.42万 - 项目类别:
Harnessing the gut microbiome to detect and quantify glycans
利用肠道微生物组来检测和量化聚糖
- 批准号:
10693304 - 财政年份:2022
- 资助金额:
$ 23.42万 - 项目类别:
Staphylococcus aureus induced itch and neuro-immune signaling in skin infections
金黄色葡萄球菌在皮肤感染中引起瘙痒和神经免疫信号传导
- 批准号:
10707178 - 财政年份:2022
- 资助金额:
$ 23.42万 - 项目类别: